Growth inhibitory effect of the human NIT2 gene and its allelic imbalance in cancers

• Published in: The FEBS journal Vol. 274; no. 11; pp. 2946 - 2956
• Main Authors: Lin, Chun‐Hung, Chung, Ming‐Yi, Chen, Wen‐Bin, Chien, Chin‐Hsiang
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Publishing Ltd 01.06.2007
• Subjects: 14-3-3 Proteins - biosynthesis; 14‐3‐3β; 14‐3‐3σ; Acid Anhydride Hydrolases - physiology; allelic imbalance; Allelic Imbalance - physiology; Aminohydrolases - genetics; Aminohydrolases - physiology; Biomarkers, Tumor - biosynthesis; Cancer; Cell growth; Cell Proliferation - drug effects; Exonucleases - biosynthesis; Exoribonucleases; G2 Phase - drug effects; G2/M arrest; Genes; Genotype & phenotype; HeLa Cells; human NIT2; Humans; Kinases; Neoplasm Proteins - biosynthesis; Neoplasm Proteins - physiology; Neoplasms - genetics; Oncology; Proteins; Proteomics; Proto-Oncogene Proteins c-akt - biosynthesis; Subcellular Fractions - chemistry; Tissues; Tumors; Up-Regulation
• ISSN: 1742-464X; 1742-4658
• DOI: 10.1111/j.1742-4658.2007.05828.x

The mammalian nitrilase (Nit) protein is a member of the nitrilase superfamily whose function remains to be characterized. We now show that the nitrilase family member 2 gene (NIT2) is ubiquitously expressed in multiple tissues and encodes protein mainly distributed in the cytosol. Ectopic expression of Nit2 in HeLa cells was found to inhibit cell growth through G2 arrest rather than by apoptosis. Consistent with this, proteomic and RT‐PCR analyses showed that Nit2 up‐regulated the protein and mRNA levels of 14‐3‐3σ, an inhibitor of both G2/M progression and protein kinase B (Akt)‐activated cell growth, and down‐regulated 14‐3‐3β, a potential oncogenic protein. Genotype analysis in four types of primary tumor tissues showed 12.5–38.5% allelic imbalance surrounding the NIT2 locus. The results demonstrated that NIT2 plays an important role in cell growth inhibition and links to human malignancies, suggesting that Nit2 may be a potential tumor suppressor candidate.